Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Tumeurs solides
- | Specialty :
- Immunothérapie - Vaccinothérapie
Extract
MEDITREM D4190C00010 - MII41910-419010 : A Phase 1 Study of MEDI4736 (Anti-PD-L1 Antibody) in Combination with Tremelimumab (Anti-CTLA-4 Antibody) in Subjects with Advanced Solid Tumors.